Found: 15
Select item for more details and to access through your institution.
Transient red blood cell agglutination after Magrolimab administration in acute myeloid leukemia.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Poly(ADP‐ribose)polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 787, doi. 10.1111/bjh.17863
- By:
- Publication type:
- Article
Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. 1054, doi. 10.1111/bjh.16768
- By:
- Publication type:
- Article
Large deletions of the 5′ region of IKZF1 lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. e155, doi. 10.1111/bjh.15994
- By:
- Publication type:
- Article
Ikaros cooperates with Notch activation and antagonizes TGFβ signaling to promote pDC development.
- Published in:
- PLoS Genetics, 2018, v. 14, n. 7, p. 1, doi. 10.1371/journal.pgen.1007485
- By:
- Publication type:
- Article
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 111, doi. 10.1111/ejh.13626
- By:
- Publication type:
- Article
Correction: Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0242211
- By:
- Publication type:
- Article
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7175, doi. 10.1002/cam4.5459
- By:
- Publication type:
- Article
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0238795
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 34, doi. 10.1016/j.clml.2021.07.027
- By:
- Publication type:
- Article
Validation by Real-life Data of the New Radiological Criteria of the Revised and Updated Consensus Definition for Invasive Fungal Diseases.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 10, p. 2773, doi. 10.1093/cid/ciaa205
- By:
- Publication type:
- Article
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-023-01515-4
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation for acquired pure red cell aplasia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E294, doi. 10.1002/ajh.25609
- By:
- Publication type:
- Article
Unusual presentation of toxoplasmosis with gastro‐intestinal involvement in HLA non‐identical stem cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Case Study